FR2033961A5 - - Google Patents

Info

Publication number
FR2033961A5
FR2033961A5 FR7003974A FR7003974A FR2033961A5 FR 2033961 A5 FR2033961 A5 FR 2033961A5 FR 7003974 A FR7003974 A FR 7003974A FR 7003974 A FR7003974 A FR 7003974A FR 2033961 A5 FR2033961 A5 FR 2033961A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7003974A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amicon Corp
Original Assignee
Amicon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicon Corp filed Critical Amicon Corp
Application granted granted Critical
Publication of FR2033961A5 publication Critical patent/FR2033961A5/fr
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/18—Apparatus therefor
FR7003974A 1969-02-05 1970-02-04 Expired FR2033961A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79692869A 1969-02-05 1969-02-05

Publications (1)

Publication Number Publication Date
FR2033961A5 true FR2033961A5 (fr) 1970-12-04

Family

ID=25169415

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7003974A Expired FR2033961A5 (fr) 1969-02-05 1970-02-04

Country Status (10)

Country Link
US (1) US3541005A (fr)
JP (1) JPS4931431B1 (fr)
BE (1) BE745442A (fr)
DE (1) DE2005260A1 (fr)
DK (1) DK141682B (fr)
FR (1) FR2033961A5 (fr)
GB (1) GB1307331A (fr)
NL (1) NL7001662A (fr)
SE (1) SE350702B (fr)
ZA (1) ZA70548B (fr)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2254860C3 (de) * 1971-11-26 1984-03-29 Heinrich Frings Gmbh & Co Kg, 5300 Bonn Ultrafiltrationsverfahren für Flüssigkeiten, die Mikroorganismen, Makromoleküle oder andere kleine Feststoffteilchen enthalten
JPS568476U (fr) * 1979-06-30 1981-01-24
JPS56110625A (en) * 1980-02-05 1981-09-01 Takeda Chem Ind Ltd Separating method of blood plasma and apparatus for the same
US4735726A (en) * 1981-07-22 1988-04-05 E. I. Du Pont De Nemours And Company Plasmapheresis by reciprocatory pulsatile filtration
US4639317A (en) * 1982-02-16 1987-01-27 E. I. Du Pont De Nemours And Company Plasmapheresis filtration module having improved sealing means
US4636312A (en) * 1982-02-16 1987-01-13 E. I. Du Pont De Nemours And Company Plasmapheresis filtration module having improved end plate
US4640776A (en) * 1982-02-16 1987-02-03 E. I. Du Pont De Nemours And Company Plasmapheresis filtration module having pressure balancing and sealing means
US4769150A (en) * 1982-02-16 1988-09-06 E. I. Du Pont De Nemours And Company Method and apparatus for plasmapheresis by reciprocatory pulsatile filtration
DE3525668A1 (de) * 1984-10-31 1986-05-07 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zur bestimmung des gehaltes an in einem loesungsmittel geloesten stoffen
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US5236689A (en) * 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US5340590A (en) * 1987-06-25 1994-08-23 Alza Corporation Delivery system with bilayer osmotic engine
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US5273752A (en) * 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US4986918A (en) * 1989-11-08 1991-01-22 Romicon Inc. Membrane separation system and method of operation
US5030216A (en) * 1989-12-15 1991-07-09 Alza Corporation Osmotically driven syringe
US5474785A (en) * 1990-01-24 1995-12-12 Alza Corporation Delivery system comprising means for controlling internal pressure
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5532003A (en) * 1994-01-18 1996-07-02 Alza Corporation Pentoxifylline therapy
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
EP0749038A1 (fr) 1995-06-16 1996-12-18 Minnesota Mining And Manufacturing Company Matériaux photographiques sensible à la lumière comprenant des grains tabulaires à l'halogénure d'argent et des dérivés d'azodicarbonamide
US6110499A (en) * 1997-07-24 2000-08-29 Alza Corporation Phenytoin therapy
US6514530B2 (en) 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape
US20040062799A1 (en) * 1997-09-29 2004-04-01 Ayer Atul D. Therapeutic composition and delivery system for administering drug
AU1534699A (en) 1997-12-05 1999-06-28 Alza Corporation Osmotic dosage form comprising first and second coats
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
US6375957B1 (en) * 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
US6245357B1 (en) 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US20010038855A1 (en) * 1998-06-05 2001-11-08 Desjardin Michael A. Dosage form for administering prescribed dose
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
GB9822854D0 (en) 1998-10-21 1998-12-16 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
NZ511465A (en) * 1998-11-02 2003-10-31 Alza Corp Controlled delivery of active agents
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
ATE292453T1 (de) * 1999-12-09 2005-04-15 Alza Corp Antivirale arznei
KR100968128B1 (ko) 2000-10-30 2010-07-06 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
JP4256259B2 (ja) 2001-07-18 2009-04-22 ユーロ−セルティーク エス．エイ． オキシコドン及びナロキソンの医薬配合物
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
EP1492509A1 (fr) * 2001-12-18 2005-01-05 ALZA Corporation Forme posologique permettant d'obtenir des modeles d'apport de medicaments variant dans le temps
CN1606432A (zh) * 2001-12-19 2005-04-13 阿尔扎公司 用于增加亲水性大分子的口服生物利用度的制剂和剂型
JP2005513095A (ja) * 2001-12-19 2005-05-12 アルザ・コーポレーシヨン 治療剤の制御送達のための調合物＆投薬形態物
CN100411611C (zh) 2002-04-05 2008-08-20 欧洲凯尔蒂克公司 用于持续,不变且独立释放活性化合物的基质
BR0309620A (pt) * 2002-04-29 2005-03-15 Alza Corp Métodos e formas de dosagem para liberação controlada de oxicodona
US20050106249A1 (en) * 2002-04-29 2005-05-19 Stephen Hwang Once-a-day, oral, controlled-release, oxycodone dosage forms
IL165361A0 (en) * 2002-05-31 2006-01-15 Alza Corp Dosage forms and compositions for osmotic deliveryof variable dosages of oxycodone
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
MXPA05001184A (es) * 2002-07-29 2005-09-12 Johnson & Johnson Formulaciones y formas de dosificacion para administracion controlada de topiramato.
US20060134196A1 (en) * 2002-12-17 2006-06-22 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
JP2006522016A (ja) * 2003-01-14 2006-09-28 アルザ・コーポレーシヨン 改変された粘度の層を用いる方法および投薬形態物
JP2006517593A (ja) * 2003-02-11 2006-07-27 アルザ・コーポレーシヨン 投薬形態物の層形状修飾方法およびそのような修飾を受けさせた投薬形態物
EP1905435A3 (fr) 2003-03-11 2008-05-14 Euro-Celtique S.A. Régime de dosage de titrage pour tramadol à libération contrôlée
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
WO2004112724A2 (fr) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions et procedes de traitement du vih
WO2005016306A2 (fr) * 2003-08-06 2005-02-24 Alza Corporation Administration reguliere de topiramate pendant une periode prolongee a formulation de dispersion amelioree
EP1658048A2 (fr) * 2003-08-22 2006-05-24 ALZA Corporation Administration progressive de topiramate sur une duree prolongee
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
PL1663229T3 (pl) 2003-09-25 2010-09-30 Euro Celtique Sa Farmaceutyczne kombinacje hydrokodonu i naltreksonu
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
CA2540308C (fr) 2003-09-26 2013-08-06 Alza Corporation Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
CA2540059C (fr) * 2003-09-26 2013-08-06 Alza Corporation Formulations a liberation commandee presentant un taux croisssant de liberation
AU2004291081A1 (en) * 2003-11-14 2005-06-02 Alza Corporation Controlled release of topirimate in liquid dosage forms
US20050158365A1 (en) * 2003-12-22 2005-07-21 David Watson Drug delivery device with mechanical locking mechanism
US20050136095A1 (en) * 2003-12-22 2005-06-23 Brian Levy Drug delivery device with suture ring
AU2004308973A1 (en) * 2003-12-23 2005-07-14 Alza Corporation Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
CA2550699A1 (fr) * 2003-12-29 2005-07-21 Alza Corporation, Inc. Nouvelles preparations de medicaments et formes posologiques de topiramate
JP2007517061A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン 新規薬剤組成物及び投与形態物
TWI483944B (zh) 2004-03-30 2015-05-11 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
US20060009425A1 (en) * 2004-05-28 2006-01-12 Leticia Delgado-Herrera Oral formulations of paricalcitol
EP1604666A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement de la bronchopneumopathie chronique obstructive
EP1604667A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
WO2005123039A1 (fr) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Formulations de prevention des abus
WO2006007323A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Formes posologiques pour agents pharmaceutiques exempts d'acides a taux de dissolution et/ou de solubilite bas
WO2006007354A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Systeme d'administration par voie orale comprenant un complexe medicament/polymere
WO2006007351A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Forme posologique orale a liberation controlee par compression
KR20070043894A (ko) * 2004-08-19 2007-04-25 알자 코포레이션 제어 방출형 나노입자 활성제 제제 제형 및 방법
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20060067980A1 (en) * 2004-09-30 2006-03-30 Bausch & Lomb Incorporated Capsule for encasing tablets for surgical insertion into the human body
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PT2377557T (pt) 2004-11-24 2017-02-07 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US20060134162A1 (en) * 2004-12-16 2006-06-22 Larson Christopher W Methods for fabricating a drug delivery device
CA2596029A1 (fr) * 2005-01-27 2006-08-03 David E. Edgren Forme galenique osmotique orale comprenant une membrane a flux eleve
BRPI0606339A2 (pt) * 2005-01-28 2009-06-16 Euro Celtique Sa formas farmacêuticas resistentes a álcool
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US20060257484A1 (en) * 2005-04-19 2006-11-16 Hwang Stephen S Combination of tramadol and substances that comprise gabapentin
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
EP1813276A1 (fr) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Formes de dosage inviolables
EP2119442A4 (fr) 2006-12-28 2010-12-15 Astellas Pharma Inc Composition pharmaceutique à libération entretenue de tacrolimus
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
MX2009006114A (es) * 2007-03-02 2009-11-10 Meda Pharmaceuticals Inc Composiciones que comprenden carisoprodol y metodos de uso de las mismas.
WO2008151071A1 (fr) * 2007-05-30 2008-12-11 Neos Therapeutics, Lp Modification de libération de médicament dans des suspensions de systèmes de résine ioniques
US20090087484A1 (en) * 2007-09-28 2009-04-02 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
NZ595663A (en) 2009-03-10 2013-11-29 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
PL2554168T3 (pl) 2010-03-29 2018-05-30 Astellas Pharma Inc. Kompozycja farmaceutyczna do kontrolowanego uwalniania
CN103370058A (zh) 2010-12-22 2013-10-23 普渡制药公司 包覆的抗篡改控制释放剂型
EP2654733B1 (fr) 2010-12-23 2016-04-06 Purdue Pharma LP Formes pharmaceutiques solides à usage oral résistant à la contrefaçon
KR101946104B1 (ko) 2012-07-16 2019-02-08 로드스 테크놀로지즈 개선된 오피오이드 합성을 위한 방법
JP6236447B2 (ja) 2012-07-16 2017-11-22 ローズ テクノロジーズ 改善されたオピオイド合成方法
AU2013337605B2 (en) 2012-11-02 2018-03-01 Murray & Poole Enterprises, Ltd. Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
AU2014215478B2 (en) 2013-02-05 2018-09-13 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
MX2015015036A (es) 2013-04-30 2016-02-09 Abbvie Inc Metodos para mejorar los perfiles de lipidos utilizando atrasentan.
CA2918004C (fr) 2013-07-23 2018-11-20 Euro-Celtique S.A. Combinaison d'oxycodone et de naloxone pour utilisation dans le traitement de la douleur chez des patients souffrant de douleur et d'une maladie entrainant une dysbiose intestinale et/ou l'augmentation du risque de translocation bacterienne intestinale
MA38576B2 (fr) 2013-11-26 2020-02-28 Murray And Poole Enterprises Ltd Formulations de colchicine à libération prolongée et procédés d'utilisation de ces dernières
ES2672795T3 (es) 2014-01-15 2018-06-18 Rhodes Technologies Proceso para la síntesis mejorada de oximorfona
JP2017502991A (ja) 2014-01-15 2017-01-26 ローズ テクノロジーズ 改良されたオキシコドン合成のための方法
WO2016132217A1 (fr) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Procédé d'amélioration de la thérapie par agoniste du récepteur gaba-b
EP3061501A1 (fr) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition pour le traitement de l'acné
EP3998066A1 (fr) 2015-04-17 2022-05-18 Murray And Poole Enterprises Limited Salicylate de colchicine et ses utilisations
EP3117825A1 (fr) 2015-07-16 2017-01-18 Rottapharm S.p.A. Formulation orale comprenant de la berbérine et un extrait de morus alba
WO2017222575A1 (fr) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Procédé de préparation de formulations orales dissuasives d'abus plus stables
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
EA202091736A1 (ru) 2018-02-02 2020-10-19 Марри Энд Пул Энтерпрайзес, Лтд. Применение колхицина для ингибирования роста опухоли и метастазов
JPWO2021029020A1 (fr) 2019-08-13 2021-02-18
WO2021089715A1 (fr) 2019-11-06 2021-05-14 Murray And Poole Enterprises, Ltd. Utilisation de colchicine dans le traitement et la prévention du cancer du poumon
LT4153136T (lt) 2020-06-10 2024-03-25 Auspex Pharmaceuticals, Inc. Osmosinės vaisto formos, apimančios deutetrabenaziną ir jo vartojimo būdai
WO2023240186A1 (fr) 2022-06-08 2023-12-14 Auspex Pharmaceuticals, Inc. Formes posologiques osmotiques comprenant de la deutétrabénazine et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211645A (en) * 1962-07-17 1965-10-12 Technicon Instr Method and apparatus for filtering sanguineous liquid streams
US3305097A (en) * 1963-05-27 1967-02-21 Scientific Industries High pressure peristaltic pump for separation apparatus

Also Published As

Publication number Publication date
SE350702B (fr) 1972-11-06
DK141682B (da) 1980-05-27
DE2005260A1 (de) 1970-10-29
US3541005A (en) 1970-11-17
ZA70548B (en) 1971-08-25
NL7001662A (fr) 1970-08-07
DK141682C (fr) 1980-10-20
JPS4931431B1 (fr) 1974-08-21
BE745442A (fr) 1970-07-16
GB1307331A (en) 1973-02-21

Similar Documents

Publication Publication Date Title
FR2033961A5 (fr)
AU2270770A (fr)
AU465452B2 (fr)
AU429630B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU427401B2 (fr)
AU425297B2 (fr)
AU410358B2 (fr)
AU442535B2 (fr)
AU442322B2 (fr)
AU438128B2 (fr)
AU428074B2 (fr)
AU442357B2 (fr)
AU428131B2 (fr)
AT308690B (fr)
AU428129B2 (fr)
AU442463B2 (fr)
AU442285B2 (fr)
AU442538B2 (fr)
AU442380B2 (fr)
AU417208B2 (fr)
AU414607B2 (fr)
AU442554B2 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse